Balvi

Latvia

5 total trials

Filter these 5 trials by phase, condition, sponsor and more.

Open in Search →

A Randomized, Double Blind, Active-Controlled Study on Efficacy and Safety of TEV-56248 in Patients with Asthma Ended recruitment

2023-505435-12-00 5 2024-06-04 Asthma
Efficacy and safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund maintenance therapy Ended

2022-502208-64-00 4 2023-11-25 Asthma
A Multi-national Phase IIIb Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years o … Ended

2023-509833-38-00 5 2023-09-20 Birch Pollen-induced Allergic Rhinoconjunctivitis
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose ranging Study to Assess the Efficacy and Safety of CDX 0159 in Patients with Ch … Ended

2024-516988-87-00 4 2022-11-09 Chronic Inducible Urticaria
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy Ended

2023-510174-13-00 5 2021-06-17 Chronic Obstructive Pulmonary Disease (COPD)

Showing 1–5 of 5 trials